ArticleJournal of the European Academy of Dermatology and Venereology : JEADV2026

Dupilumab in moderate-to-severe prurigo nodularis: Real-world data from early access program.

Marie Jachiet et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.